John Hood - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

John Hood

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Bioorganic & Medicinal Chemistry Letters|August 26, 2006

Discovery and preliminary structure-activity relationship studies of novel benzotriazine based compounds as Src inhibitorsGlenn Noronha, Kathy Barrett, Jianguo Cao, et al.

Cancer Letters|September 28, 2019

The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer modelsBetty Y Tam, Kevin Chiu, Heekyung Chung, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025

Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing CancersJason J Zoeller, Ravinder Tammali, Roger B Dodd, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Bioorganic & Medicinal Chemistry Letters|August 26, 2006

Discovery and preliminary structure-activity relationship studies of novel benzotriazine based compounds as Src inhibitorsGlenn Noronha, Kathy Barrett, Jianguo Cao, et al.

Cancer Letters|September 28, 2019

The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer modelsBetty Y Tam, Kevin Chiu, Heekyung Chung, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2025

Derivation of AZD5335, a Novel FRα-Targeted TOP1i-Loaded ADC, for the Treatment of FRα-Expressing CancersJason J Zoeller, Ravinder Tammali, Roger B Dodd, et al.

Pageof 5